Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Revicki

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Antiviral Therapy|February 22, 2000
Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3D A Revicki, C Swartz, A W Wu, et al.
Journal of Clinical Epidemiology|December 1, 1994
Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertensionD A Revicki, H Allen, K Bungay, et al.
Pharmacoeconomics|October 28, 1999
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trialS H Hamilton, D A Revicki, E T Edgell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 1999
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trialD A Revicki, L A Genduso, S H Hamilton, et al.
Anesthesiology|October 1, 1990
Physician payment reform: anesthesiology as a case studyD A Revicki, F K Orkin, B R Luce, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux diseaseD A Revicki, J A Crawley, M W Zodet, et al.
Neurogastroenterology and Motility|January 31, 2012
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)D A Revicki, M Camilleri, B Kuo, et al.
Medical Care|February 15, 2001
Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniquesD A Revicki, K Gold, D Buckman, et al.
Hospital & Community Psychiatry|August 1, 1990
Cost-effectiveness of clozapine for treatment-resistant schizophrenic patientsD A Revicki, B R Luce, J M Weschler, et al.
Journal of the American Dental Association (1939)|May 1, 1984
Use of orally administered diazepam in the reduction of dental anxietyJ P Baker, H J May, D A Revicki, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Antiviral Therapy|February 22, 2000
Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3D A Revicki, C Swartz, A W Wu, et al.
Journal of Clinical Epidemiology|December 1, 1994
Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertensionD A Revicki, H Allen, K Bungay, et al.
Pharmacoeconomics|October 28, 1999
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trialS H Hamilton, D A Revicki, E T Edgell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 1999
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trialD A Revicki, L A Genduso, S H Hamilton, et al.
Anesthesiology|October 1, 1990
Physician payment reform: anesthesiology as a case studyD A Revicki, F K Orkin, B R Luce, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux diseaseD A Revicki, J A Crawley, M W Zodet, et al.
Neurogastroenterology and Motility|January 31, 2012
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)D A Revicki, M Camilleri, B Kuo, et al.
Medical Care|February 15, 2001
Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniquesD A Revicki, K Gold, D Buckman, et al.
Hospital & Community Psychiatry|August 1, 1990
Cost-effectiveness of clozapine for treatment-resistant schizophrenic patientsD A Revicki, B R Luce, J M Weschler, et al.
Journal of the American Dental Association (1939)|May 1, 1984
Use of orally administered diazepam in the reduction of dental anxietyJ P Baker, H J May, D A Revicki, et al.
Pageof 12